John Graham
Chief Executive Officer
Zuellig Pharma
Zuellig Pharma
John Graham is a senior healthcare executive and leader with more than three decades of global experience in the pharmaceutical and biotech industries. A recognized expert across multiple dimensions within the sector, John has supported the success of several multinational organizations through a combination of senior operational roles and c-suite strategic advisory.
He is currently Chief Executive Officer of Zuellig Pharma, a multi-billion-dollar healthcare solutions business covering 17 markets with over 12,000 employees. The organization serves more than 200,000 medical facilities and works with over 450 clients, including the top 20 pharmaceutical companies in the world.
John leads the Zuellig Pharma Executive Management team with a purpose to make healthcare more accessible and sustainable across Asia. His vision is to transform Zuellig Pharma into an indispensable strategic partner to those engaged in the Asian healthcare ecosystem, by providing a full spectrum of innovative and integrated solutions across the value chain.
Under his leadership, Zuellig Pharma has continued to deliver a full spectrum of innovative and integrated solutions across the value chain as a strategic partner for the healthcare ecosystem.
Prior to Zuellig Pharma, John was the Chief Executive Officer of Invida, where he successfully positioned the business as a leading commercialization specialist in the region. During his tenure, John transformed and executed the sale of the company in 2011 to the Menarini Group, Italy’s largest pharma company. The company continued to thrive under his leadership as Menarini Asia Pacific, until his departure in Dec 2015.
He has served in senior management roles of other blue-chip organizations, including an 18-year tenure with Aventis, where he led its Global Commercial Operations and spearheaded its global success in diabetes.
His experience is global having lived and worked in Europe, Asia, Latin America, and the United States.
John has a BSc in Biochemistry from Imperial College of Science and Technology, London.
He is currently Chief Executive Officer of Zuellig Pharma, a multi-billion-dollar healthcare solutions business covering 17 markets with over 12,000 employees. The organization serves more than 200,000 medical facilities and works with over 450 clients, including the top 20 pharmaceutical companies in the world.
John leads the Zuellig Pharma Executive Management team with a purpose to make healthcare more accessible and sustainable across Asia. His vision is to transform Zuellig Pharma into an indispensable strategic partner to those engaged in the Asian healthcare ecosystem, by providing a full spectrum of innovative and integrated solutions across the value chain.
Under his leadership, Zuellig Pharma has continued to deliver a full spectrum of innovative and integrated solutions across the value chain as a strategic partner for the healthcare ecosystem.
Prior to Zuellig Pharma, John was the Chief Executive Officer of Invida, where he successfully positioned the business as a leading commercialization specialist in the region. During his tenure, John transformed and executed the sale of the company in 2011 to the Menarini Group, Italy’s largest pharma company. The company continued to thrive under his leadership as Menarini Asia Pacific, until his departure in Dec 2015.
He has served in senior management roles of other blue-chip organizations, including an 18-year tenure with Aventis, where he led its Global Commercial Operations and spearheaded its global success in diabetes.
His experience is global having lived and worked in Europe, Asia, Latin America, and the United States.
John has a BSc in Biochemistry from Imperial College of Science and Technology, London.